Onconova Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
N/AN/AN/AN/A
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-0.83$-0.81$-0.95$-1.16

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.11-0.91-0.51-0.56-0.59-0.25-3.25-2.71-0.74-0.82-0.51-0.59
Price/Sales ratio
89.041.901.8117.159.932.50354.09189.9260.1369.2441.519.93
Price/Book Value ratio
3.132.182.33-1.152.260.4713.240.930.481.460.490.47
Price/Cash Flow ratio
-1.23-0.69-0.63-0.56-0.53-0.26-3.54-2.20-0.83-0.87-0.56-0.26
Price/Free Cash Flow ratio
-1.23-0.69-0.63-0.56-0.53-0.26-3.54-2.20-0.83-0.87-0.56-0.26
Price/Earnings Growth ratio
0.020.010.000.010.000.000.030.040.11-0.36-0.140.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%100%100%93.80%93.80%100000000%N/A100%
Operating Profit Margin
-7968.00%-209.25%-427.38%-3270.26%-1895.92%-993.99%-10819.48%-7299.11%-8684.51%-8981.41%-8223.89%-993.99%
Pretax Profit Margin
-7972%-209.55%-354.36%-3059.59%-1672.14%-984.56%-10888.74%-7151.76%-8391.15%-8384.07%-7997.05%-984.56%
Net Profit Margin
-7960.25%-209.31%-354.61%-3061.24%-1675.32%-985.02%-10890.47%-7003.53%-8097.78%-8384.07%-7997.05%-985.02%
Effective Tax Rate
-0.02%-0.06%-0.07%-0.05%0.60%-0.04%-0.01%2.07%3.49%N/AN/A-0.04%
Return on Assets
-134.52%-102.27%-84.65%-483.87%-114.78%-90.82%-125.87%-28.53%-46.48%-83.53%-68.85%-114.78%
Return On Equity
-279.94%-239.55%-457.69%206.07%-381.90%-185.78%-407.40%-34.31%-64.64%-177.54%-76.12%-381.90%
Return on Capital Employed
-171.91%-151.33%-181.31%515.04%-245.46%-141.06%-250.80%-33.41%-62.65%-150.76%-88.99%-245.46%
Liquidity Ratios
Current Ratio
4.573.042.270.492.102.831.97N/AN/AN/A4.892.10
Quick Ratio
4.572.822.110.492.102.821.969.054.872.304.822.10
Cash ratio
4.242.602.100.402.012.741.899.004.812.254.812.01
Days of Sales Outstanding
N/A47.912.0427.3610.4016.3858.4645.2246.8329.0731.2210.40
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A756.072.52K-0.00N/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A801.292.57K29.06N/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A71.87K100.63K-0.00N/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A-71.07K-98.05K29.07N/AN/A
Debt Ratios
Debt Ratio
0.120.150.18N/A0.23N/AN/AN/AN/A-148.78K0.280.23
Debt Equity Ratio
0.250.370.97N/A0.77N/AN/AN/AN/A-316.24K0.39N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.200.270.49N/A0.43N/AN/AN/AN/A1.00N/AN/A
Interest Coverage Ratio
-31.87KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-9.98-8.39-3.77N/A-5.45N/AN/AN/AN/A0.00N/A-5.45
Company Equity Multiplier
2.082.345.40-0.423.322.043.231.201.392.121.392.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-72.06-2.72-2.85-30.26-18.48-9.54-99.89-86.22-72.09-79.34-73.16-9.54
Free Cash Flow / Operating Cash Flow Ratio
1.0011111.001.00111.0011.00
Cash Flow Coverage Ratio
-9.98-8.39-3.77N/A-5.45N/AN/AN/AN/A0.00N/A-5.45
Short Term Coverage Ratio
-9.98-8.39-3.77N/A-5.45N/AN/AN/AN/A0.00N/A-5.45
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A